高脂血症
血脂异常
医学
甘油三酯
疾病
植物甾醇
胆固醇
糖尿病
机制(生物学)
冠心病
内科学
内分泌学
生物
食品科学
认识论
哲学
作者
Jingxia Lu,Zu‐Guo Zheng,Zhimeng Xu,Hua Yang,Ping Li
出处
期刊:PubMed
日期:2019-11-01
卷期号:44 (21): 4552-4559
被引量:2
标识
DOI:10.19540/j.cnki.cjcmm.20190424.401
摘要
Hyperlipidemia,as one of the severe risk factors of cardiovascular disease,could easily trigger atherosclerosis,coronary heart disease,peripheral vascular disease,pancreatitis,etc.,and could also increase the incidence of type 2 diabetes and fatty liver disease. Improving dyslipidemia could slow down the progression of atherosclerosis and reduce the risk of coronary heart disease. This is of great importance for prevention and treatment of cardiovascular disease. Phytosterols are natural active ingredients in plants. Many researches have shown that phytosterols have significant lipid-lowering activity,which could effectively lower blood cholesterol and triglyceride levels. Foods containing phytosterols have been widely used as therapeutic diets for improving dyslipidemia. In the early years,it was believed that the lipid-lowering effect of phytosterols was achieved by competitively inhibiting the absorption of dietary cholesterol in the intestine since phytosterols had similar chemical structures with cholesterol. In further researches in recent years,more progress has been made in the lipid-lowering mechanisms of phytosterols. In this paper,PubMed and Web of Science were used to review the cholesterol-lowering and triglyceride-lowering mechanisms of phytosterols according to the available data published,so as to use phytosterols more rationally in clinical application to improve hyperlipidemia and other induced diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI